Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NVD003 Compared With Iliac Crest Bone Graft in Pediatric Participants With Congenital Pseudarthrosis of the Tibia
NCT07112443Phase 3Recruiting
- Sponsor
- Novadip Biosciences
- Start
- Sep 2025
- Primary completion
- Oct 2026
- Modality
- Implantable Devices, Implantable Hydrogels, Cell Therapies
- Countries
- 4
01
Overview
A Phase 3 trial of NVD-003 in congenital pseudarthrosis of the tibia (CPT), sponsored by Novadip Biosciences. Started Sep 2025; status: recruiting.
02
Drugs
NVD-003
03
Conditions
congenital pseudarthrosis of the tibia (CPT)
Beyond the preview
Go deeper on NCT07112443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07112443.